These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71. Levels and nature of immunoregulatory mechanisms in pregnancy. Voisin GA Contrib Gynecol Obstet; 1985; 14():36-43. PubMed ID: 3905252 [No Abstract] [Full Text] [Related]
72. [Problems of immunocompetence in obstetric physiopathology]. Stoppelli I Minerva Ginecol; 1973 Jan; 25(1):1-7. PubMed ID: 4633207 [No Abstract] [Full Text] [Related]
73. Histoincompatibility and the survival of the fetus: current controversies. Simmons RL Transplant Proc; 1969 Mar; 1(1):47-52. PubMed ID: 4257481 [No Abstract] [Full Text] [Related]
74. Transplantation--nature's success. Anderson JM Lancet; 1971 Nov; 2(7733):1077-82. PubMed ID: 4106922 [No Abstract] [Full Text] [Related]
76. Editorial: Adaptive Immunity in Pregnancy. Piccinni MP; Robertson SA; Saito S Front Immunol; 2021; 12():770242. PubMed ID: 34671364 [No Abstract] [Full Text] [Related]
77. Immunology of the maternal-placental interface in normal pregnancy. Colbern GT; Main EK Semin Perinatol; 1991 Jun; 15(3):196-205. PubMed ID: 1718044 [No Abstract] [Full Text] [Related]
78. Immunologic mechanisms in the maternal-fetal relationship. Lewis JE; Coulam CB; Moore SB Mayo Clin Proc; 1986 Aug; 61(8):655-65. PubMed ID: 3523061 [TBL] [Abstract][Full Text] [Related]
79. Survival of the genetically incompatible fetal allograft. Finn R Lancet; 1975 Apr; 1(7911):835-8. PubMed ID: 48059 [TBL] [Abstract][Full Text] [Related]
80. Suppressive cellular and molecular activities in maternofetal immune interactions; suppressor cell activity, prostaglandins, and alpha-fetoproteins. Olding LB; Papadogiannakis N; Barbieri B; Murgita RA Curr Top Microbiol Immunol; 1997; 222():159-87. PubMed ID: 9257491 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]